Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Azanza Perea JR. [Liposomal amphotericin B: Clinical pharmacology, pharmacokinetics and pharmacodynamics]. Rev Iberoam Micol 2021;38:52-55. [PMID: 33992527 DOI: 10.1016/j.riam.2021.02.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2021] [Accepted: 02/16/2021] [Indexed: 11/19/2022] Open

For:	Azanza Perea JR. [Liposomal amphotericin B: Clinical pharmacology, pharmacokinetics and pharmacodynamics]. Rev Iberoam Micol 2021;38:52-55. [PMID: 33992527 DOI: 10.1016/j.riam.2021.02.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2021] [Accepted: 02/16/2021] [Indexed: 11/19/2022] Open

Number

Cited by Other Article(s)

Pemán J, Quindós G. [Liposomal amphotericin B: thirty years of a highly effective therapy for the treatment of invasive mycoses]. Rev Iberoam Micol 2021;38:39-41. [PMID: 34304961 DOI: 10.1016/j.riam.2021.04.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2021] [Accepted: 04/23/2021] [Indexed: 11/16/2022] Open